Iressa | THE "NEW" PROSTATE CANCER INFOLINK

Follow The "New" Prostate Cancer InfoLink news blog on TWITTER or FACEBOOK.
The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of

Prostate Cancer International.
Awards
Other PCI web sites

El Cáncer de Próstata Latinoamérica
Prostate Cancer Africa
Prostate Cancer Caribbean
Solidarité Prostate InfoLink
Copyright © 2008-18 Prostate Cancer International, Inc.

Prostate cancer news reports: January 6, 2010

Posted on January 6, 2010 by Sitemaster

Recent reports have addressed the following issues related to prostate cancer:

How many biopsy cores is the right number?
How “open” surgeons have adapted to laparoscopic surgery
Hypoxia, the tumor environment, and how it affects treatment
Gefitinib + radiation therapy in intermediate- and high-risk prostate cancer
Fractures, prostate cancer, and androgen deprivation … READ MORE …

Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: ADT, androgen deprivation therapy, biopsy, fractures, gefitinib, hypoxia, Iressa, microenvironment, radical prostatectomy, tumor | Leave a comment »

The prostate cancer news report: Tuesday, May 5, 2009

Posted on May 5, 2009 by Sitemaster

We are returning to “normal” today with the standard “news reports.” Today’s items deal with:

Evolving biomarkers and new tests and their future application
MRI in diagnosis, staging, and prognosis of prostate cancer
Intraprostatic injection of LHRH agonists and antagonists: is it viable?
Gefitinib in HRPC: no evident impact on quality of life … READ MORE …

Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: agonist, antagonist, biomarkers, gefitinib, Iressa, LHRH, magnetic resonance imaging, MRI | 2 Comments »